These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36746274)

  • 41. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
    Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli.
    Rodríguez-Villodres Á; Gutiérrez Linares A; Gálvez-Benitez L; Pachón J; Lepe JA; Smani Y
    Microbiol Spectr; 2021 Oct; 9(2):e0080121. PubMed ID: 34668721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of blaOXA-48-like genes in carbapenemase producing Klebsiella spp. isolates].
    Kahraman EP; Toptan H; Otlu B; Köroğlu M; Altındiş M
    Mikrobiyol Bul; 2019 Apr; 53(2):134-143. PubMed ID: 31130118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae.
    Bogaerts P; Naas T; Saegeman V; Bonnin RA; Schuermans A; Evrard S; Bouchahrouf W; Jove T; Tande D; de Bolle X; Huang TD; Dortet L; Glupczynski Y
    J Antimicrob Chemother; 2017 Sep; 72(9):2469-2477. PubMed ID: 28859446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
    Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First Occurrence of the OXA-198 Carbapenemase in
    Bonnin RA; Jousset AB; Gauthier L; Emeraud C; Girlich D; Sauvadet A; Cotellon G; Jové T; Dortet L; Naas T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic and genotypic detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Accra, Ghana.
    Dwomoh FP; Kotey FCN; Dayie NTKD; Osei MM; Amoa-Owusu F; Bannah V; Alzahrani FM; Halawani IF; Alzahrani KJ; Egyir B; Donkor ES
    PLoS One; 2022; 17(12):e0279715. PubMed ID: 36584159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing
    Jeong S; Lee N; Park MJ; Jeon K; Kim HS; Kim HS; Kim JS; Song W
    Ann Lab Med; 2022 Jan; 42(1):36-46. PubMed ID: 34374347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015-2017.
    Peirano G; Chen L; Nobrega D; Finn TJ; Kreiswirth BN; DeVinney R; Pitout JDD
    Emerg Infect Dis; 2022 May; 28(5):924-31. PubMed ID: 35451367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of fecal carriage of Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among food handlers at the University of Gondar, Northwest Ethiopia.
    Amare A; Eshetie S; Kasew D; Moges F
    PLoS One; 2022; 17(3):e0264818. PubMed ID: 35298493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diversity of Carbapenemase-Producing Escherichia coli Isolates in France in 2012-2013.
    Gauthier L; Dortet L; Cotellon G; Creton E; Cuzon G; Ponties V; Bonnin RA; Naas T
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
    Bedenić B; Sardelić S; Bogdanić M; Zarfel G; Beader N; Šuto S; Krilanović M; Vraneš J
    Arch Microbiol; 2021 May; 203(4):1825-1831. PubMed ID: 33507339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Migratory White Stork (Ciconia ciconia): A Potential Vector of the OXA-48-Producing Escherichia coli ST38 Clone in Algeria.
    Bouaziz A; Loucif L; Ayachi A; Guehaz K; Bendjama E; Rolain JM
    Microb Drug Resist; 2018 May; 24(4):461-468. PubMed ID: 29022829
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of the Rapidec®Carba NP assay for the detection of different carbapenemases in Klebsiella pneumoniae and Escherichia coli strains.
    Kansak N; Çalık Ş; Arıcı N; Adaleti R; Aksaray S; Gönüllü N
    Indian J Med Microbiol; 2022; 40(4):516-520. PubMed ID: 36002355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model.
    Hertz FB; Andreasen MR; Almind SR; Nielsen KL; Hansen KH; Jelsbak L; Frimodt-Møller N; Schønning K
    Int J Antimicrob Agents; 2022 Apr; 59(4):106543. PubMed ID: 35134504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a novel carbapenem-hydrolysing β-lactamase OXA-1041 in Escherichia coli.
    Wu S; Feng Y; Yang Y; Zhu K; Wang S; Wang X; Li GB; Zong Z
    J Antimicrob Chemother; 2023 May; 78(5):1288-1294. PubMed ID: 36995982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.